The Commonwealth Foundation for Cancer Research in Virginia announced Wednesday it will donate $20 million to the Bridge Project in an effort to drive more cancer research projects into clinical trials, reports Stat.
The donation, which will be spread out over a period of five years, will double the number of grants given to scientists each year, reports Stat. Bridge funds teams of scientists, bioengineers, and clinicians from both the Koch Institute for Integrative Cancer Research at MIT and the Dana-Farber/Harvard Cancer Center.
“We want to break through the barriers of non-responsive or minimally responsive tumors and elevate them to the status of being imminently treatable,’’ Dr. David Livingston, deputy director of the Dana-Farber/Harvard Cancer Center, told Stat.
In the past, the teams have developed new technology to detect previously unseen melanomas, created drug delivery devices that reduce side effects, and rooted out resistant cancer cells in leukemia patients.
Read the full story at Stat.